← Leaderboards
W. Michael Hooten
Mayo Clinic Rochester
$6,086,953
Attributed
$6,810,912
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–23$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,810,912 · 4
By mechanism
U01$5,097,882 · 1
R21$859,209 · 2
UH3$853,821 · 1
Top collaborators
- Jungwei Wilfred Fan2 shared
- Haiquan Li2 shared
- Kah-Whye Peng1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Prashanthi Vemuri$20,262,102
- Hilal Maradit Kremers$11,722,206
- Jennifer Lynn St Sauver$8,545,756
- Andrew D Rule$13,956,498
- Vesna D Garovic$4,277,142
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPainAdultPharmaceutical PreparationsCharacteristicsEnvironmentRecordsData SetOpioidPatient Self-ReportInnovationElementsTrainingTranslational ResearchClinicPublic HealthPain ManagementInstitutionSocialResearch PersonnelMediatingFutureMedicalDisincentive
Grant awards (9)
Identify the heterogeneity and commonality of chronic overlapping pain conditions (COPCs) through phenotypic and genomic perspectives$193,694
R21 · FY2023 · DE
Unintended Prolonged Opioid Use$1,161,805
U01 · FY2022 · TR · contact PI
Identify the heterogeneity and commonality of chronic overlapping pain conditions (COPCs) through phenotypic and genomic perspectives$251,879
R21 · FY2022 · DE
Unintended Prolonged Opioid Use$1,390,976
U01 · FY2021 · TR · contact PI
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse$853,821
UH3 · FY2021 · DA
Unintended Prolonged Opioid Use$1,411,174
U01 · FY2020 · TR · contact PI
Unintended Prolonged Opioid Use$1,133,927
U01 · FY2019 · TR · contact PI
Cognitive Behavioral Smoking Cessation Intervention for Adults with Chronic Pain$186,986
R21 · FY2010 · DA · contact PI
Cognitive Behavioral Smoking Cessation Intervention for Adults with Chronic Pain$226,650
R21 · FY2009 · DA · contact PI